CLEVELAND - Sept. 13, 2018 - TelAve -- Recognizing the lack of funding for pediatric medical device development, PediaVascular held a product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in Las Vegas. Five teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was titled Deflectable Hybrid Sheath from a team at Our Lady's Children's Hospital in Crumlin, Ireland. PediaVascular awarded the team an unrestricted $25,000 grant to continue development efforts. The award also included complimentary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.

More on TelAve News

• GlexScale launches a unified model for sustainable SaaS expansion across EMEA
• SwagHer Society Launches to Help Black Women Be Seen and Supported
• Why Philadelphia Homeowners Should Ditch Oil for Natural Gas
• Zero-Trust Architecture: NJTRX Addresses 60% of U.S. Investors' Custody Security Concerns
• Sub-Millisecond Trading Platform: HNZLLQ Introduces Unified Gateway for Philippine Digital Asset Traders

About PediaVascular: PediaVascular is a social venture formed in 2010 to address the lack of pediatric medical devices. In collaboration with fifty pediatric cardiologists PediaVascular developed a series of angiography catheters, introducers and guide wires specifically for children. They are the first and only to receive FDA clearance for pediatric use. To date, over 15,000 babies have been treated globally with PediaVascular's devices.

http://www.pediavascular.com